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Abstract 
 
The content uniformity (CU) of blend and tablet formulations is a critical property that 
needs to be well controlled in order to produce an acceptable pharmaceutical product. 
Methods that allow the formulations scientist to predict the CU accurately can greatly help 
in reducing the development efforts. This article presents a new statistical mechanical 
framework for predicting CU based on first principles at the molecular level. The tablet is 
modeled as an open system which can be treated as a grand canonical ensemble to calculate 
fluctuations in the number of granules and thus the CU. Exact analytical solutions to hard 
sphere mixture systems available in the literature are applied to derive an expression for 
the CU and elucidate the different factors that impact CU. It is shown that there is a single 
ratio,                ; that completely characterizes “granule quality” with respect 
to impact on CU. Here w and f denote the weight of granule and the fractional (w/w) assay 
of API in it. This ratio should be as small as possible to obtain best CU. We also derive 
analytical expressions which show how the granule loading impacts the CU through the 
excluded volume, which has been largely ignored in the literature to date. The model was 
tested against literature data and a large set of tablet formulations specifically made and 
analyzed for CU using a model API. The formulations covered the effect of granule size, 
percentage loading, and tablet weight on the CU. The model is able to predict the mean 
experimental coefficient of variation (CV) with good success and captures all the elements 
that impact the CU. The predictions of the model serve as a theoretical lower limit for the 
mean CV (for infinite batches or tablets) that can be expected during manufacturing 
assuming the best processing conditions. 
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INTRODUCTION 
 
Granulation is a commonly used route in pharmaceutical product development to increase 
dissolution rate, flowability, density of API, better distribution of API for low dose 
formulations, or in the case of multiparticulate systems to provide for a solid core for 
coating a release modifying polymer.  However, when granules are added to a blend 
formulation, problems of poor content uniformity (CU) may arise due to a combination of 
factors such as non-ideal granule characteristics (particle size, assay distribution), low 
tablet dose, particle size differences with excipients, and segregration during manufacturing 
operations. Therefore there is great interest in the industry to understand the interplay of 
various granule characteristics such as assay variation with particle size, particle size 
distribution, dose, and granule loading with tablet CU. Such an understanding can help 
identify conditions that would yield the best CU in tablets. Here an exact theoretical model 
for predicting the CU assuming random mixing of granules but allowing for packing effects 
within granules is presented. The results are general in nature and are applicable to tablet 
formulations with particles of any size or type such as layered/coated beads,1 pellets,2 
microspheres,3 or others. Thus, the current model can have a broad impact on the field. 
 
A number of publications have addressed the issue of predicting tablet content uniformity 
from particle size distribution of the API. Different theoretical approaches have been 
implemented. Johnson presented simple and elegant analytical calculations for the expected 
content uniformity for a given API particle size distribution assuming a Poisson distribution 
of API particles in the tablets.4 The approach was extended by Yalkowsky et al5 by assuming 
normal distribution of tablet assay. Yalkowsky et al. presented another analytical 
expression for the content uniformity from mean particle size and relative standard 
deviation. They also calculated an upper limit for mean particle diameter for a given relative 
standard deviation with log-normal particle size distribution which assured that the USP CU 
criteria was met with 99% probability. Rohrs et al.6 took a step further and incorporated the 
effect of testing limited sample size using the chi-square distribution. They identified upper 
limits for the particle mean size in order to pass the USP CU criteria with 99% confidence 
for a given particle standard deviation and target dose. Recently, Huang et al.7 presented a 
numerical simulation of tablet content uniformity from API particle size using the Monte 
Carlo simulation strategies. A nomograph was developed that can be used to define cut-off 
particle size requirements to pass the USP CU criteria with 99% certainty at a target dose. 
They also showed that the coefficient of variation and skewness are decoupled from the API 
particle size distribution and that the coefficient of variation varies inversely with the 
square root of the dose. Egermann et al have developed a model for tablet content 
uniformity (binary mixtures only) based on the binomial distribution and percolation 
theory.8-10 Thus, a good amount of insight into how API particle size determines the content 
uniformity is available in the literature. However, there is no information in the literature 
for predicting CU in multiparticulate formulations that use granules or beads. 
 
In addition, the impact of granule loading (as a proportion of tablet size) on content 
uniformity has not been systematically evaluated in the literature. Nor is it clear whether 
the observed relationships for tablets made with pure API particles would hold for tablets 
made with beads or granules. The impact of granule loading on the content uniformity has 
been discussed to some extent for e.g. by Johnson4 and Egermann.8,9 Assuming non-random 
mixing (i.e. particle packing effects) in a two component system, Johnson had proposed that 
when the API loading is between 1-10% w/w the coefficient of variation (CV) can be 
predicted roughly by multiplying the CV observed under ideal mixing conditions with the 
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weight fraction of the excipient. As commented by Johnson, extending non-random mixing 
to multicomponent systems is complicated. Egermann’s approach on the other hand is valid 
only for binary mixtures and does not take into account the particle size distribution of 
granules. Therefore, no general or first principle based solutions are available for 
incorporating the effect of the granule loading which, as we show herein, has a large impact 
on tablet CU regardless of the dose. 
 
All of the work in the literature4-10 thus far is based on the assumption of ideal mixing, with 
the exception of some results due to Johnson4 and Egermann.8,9 In ideal mixing, no regard is 
given to excluded volume which plays an important role in determining the radial 
distribution function and thus the content uniformity. Excluded volume refers to the actual 
volume occupied by the granules in a tablet, i.e. volume which is excluded for placement of 
other particles. Taking account of excluded volume ensures that no two particles occupy the 
same space. Ideal mixing is only truly valid when the excluded volume of API or granules is 
very small (for example at low doses). It is due to this reason that the current models in the 
literature cannot account for the effect of granule loading or tablet size on the content 
uniformity.  
 
Statistical mechanical models11-20 or computer simulations21-24 can yield deep insight into 
the structure of materials at the molecular level. We show that the problem of predicting 
content uniformity in blend or tablet is essentially of the same category and can be solved 
with the framework of statistical mechanics. 
 
In this article, analytical theory for hard sphere mixtures is implemented to calculate the 
number fluctuations in granules and hence the exact CU under the assumption of random 
mixing while allowing for packing effects within granules. Analytical solution to the problem 
of hard spheres became possible after the Percus-Yevick (P-Y) approximation11,12 was used 
to solve the Ornstein-Zernike equation.13 Wertheim14 and Thiele15 independently obtained 
an exact solution for the radial distribution function of a fluid of single component hard 
spheres using the P-Y approximation. While Lebowitz16,17 obtained an exact solution for the 
fluid of a mixture of hard spheres. The equation of states obtained for both the single 
component and mixture of hard spheres have been shown to be in very good agreement 
with computer simulations for the whole range of fluid densities. Therefore, these exact 
analytical solutions provide an important foundation for calculating fluid properties and are 
implemented in the current work. By modeling the granules as hard spheres we can take 
into account the excluded volume and thus account for the effect of granule loading and 
packing on the CV. In the current approach, excipients are ignored because the results are 
obtained under the assumption of random mixing of granules. Random mixing is a 
commonly used approach in statistical mechanics to understand the behavior of complex 
systems and is a good approximation in situations where there is weak interaction between 
particles. 
 
Since the current approach is based on equilibrium thermodynamics, it predicts the 
structure of the blend under equilibrium conditions only, without regard to the path taken 
to achieve that state. If one desires to know the path taken to achieve the final CU, other 
theoretical methods or simulations such as DEM (discrete element method) will be needed 
which calculate particle trajectories during processing operations.25 Since the goal of every 
system is to achieve equilibrium conditions, the current approach yields valuable insight 
into molecular factors that govern the final CU. 
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Finally, to confirm the theoretical model, its predictions were compared with literature data 
as well as an extensive tablet design study. The experimental study was conducted using 
two lots of granules manufactured from a model API. Tablets with varying dose, weight, and 
granule loading were manufactured and analyzed for CU. Good agreement was obtained 
between the predictions of the theoretical model and the experimental CV. This shows that 
the model is able to capture all the elements that impact the CV under the assumptions of 
random mixing.  
 
MATERIALS 
 
Diphenhydramine HCL USP was obtained from Letco Medical, Inc (Decatur, AL) with a 
reported purity of >99%. The API had d10, d50, and d90 of 21, 84, and 195 micron 
respectively. Mannitol 60 (Pearlitol® 160C) was obtained from Roquette Frères, France. 
Granular mannitol 2080 (MannogemTM) was obtained from SPI Pharma (Grand Haven, MI). 
Microcrystalline cellulose (Avicel®) was obtained from FMC Biopolymer (Philadelphia, PA). 
Crospovidone (Polyplasdone® XL) was obtained from ISP technologies (Calvert city, KY). 
Magnesium stearate was obtained from Mallinckrodt Inc (St. Louis, MO). Eudragit® E100 
was obtained from Evonik Röhm Pharma Polymers, Germany.  All of the above excipients 
complied with USP and Ph. Eur specifications and were used as obtained without any 
further processing. Ethyl alcohol USP was obtained from Grain Processing corporation 
(Muscatine, IA). Squalene (purity> 98%) was obtained from Sigma-Aldrich (St. Louis, MO). 
 
EXPERIMENTAL SECTION 
 
Theoretical Model 
 
In this article, a new approach to predicting content uniformity of granules in tablets or 
blend is presented. The approach is based on modeling the blend as a fluid mixture and 
applying the theory of fluctuations derived from statistical mechanics. This approach, 
combined with analytical theory of hard sphere fluid mixtures, allows us to derive a direct 
and exact model for the content uniformity based on the assumption of random mixing. A 
scheme illustrating the approach is depicted in Figure 1. 
 
Consider a volume in a given blend which corresponds to one tablet mass after accounting 
for the blend density (region  in Figure 1). This blend volume can be considered to be 
ultimately compressed into a tablet and therefore studying the drug content in this volume 
allows us to obtain an expression for the content uniformity. Let m denote the total number 
of granule types or species in the blend. Here a granule type is defined as one which has a 
unique particle size and associated assay. (Note: Granule type can be defined using any 
arbitrary criteria and is not limited to particle size/assay. However, in the present problem 
defining the type using these criteria is most relevant as shown in the included examples) 
We assume that each granule is impenetrable and is spherical. Let µi denote the chemical 
potential for granules of diameter Ri.  
 
Region  in figure 1 is “open” i.e. it can allow for granules to enter and leave. Note that the 
volume V (corresponding to one tablet) of the region  is fixed. The actual number of 
granules of each type i,   , in region  is controlled by the respective chemical potential, µi. 
In statistical mechanics, such a system where the volume, temperature, and chemical 
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potentials are fixed while allowing for the number of granules or particles to fluctuate is 
referred to as the grand canonical ensemble.23 
 
Let wi and fi denote the weight of each granule of type i and the fractional (w/w) assay of 
API in it. Then, the weight of the API in each granule of type i is ai = wi.fi. Each tablet has a 
variable number of total number of granules (N) and there is a distribution in the weight of 
the granules. Let    denote the average number of granules of type i in region . The 
variance in the number of granules of each type i is given as: 
 
                
         
                                                                                                               
 
Thus         is identical to the mean square number fluctuations of granules of type i. 
 
The dose is given as, 
 
     
 
   
                                                                                                                              
 
where    is the weight of the API in granule j. The variance in the dose can be written as,5 
 
              
 
   
  
                                       
                                                       
                                                                                                    
 
The percent coefficient of variation is then given as, 
 
   
           
 
 
 
                                                                                                                                         
 
Each of the terms in Eqs. 2 and 3 can be estimated from knowledge of the dose, particle size, 
and assay distribution with granule particle size. The only term that is non-trivial is Var(N). 
However, Var(N) can also be evaluated exactly as we show below. 
 
The total number fluctuations in a fixed volume V are given by 
 
                 
 
 
   
         
  
 
   
              
 
     
                                                      
 
In the rest of the paper, summation over all m species will not be shown explicitly and is 
understood. In the grand canonical ensemble it can be shown that,27 
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where       ; k is the Boltzmann’s constant and T is the temperature in Kelvin. Thus, the 
total number fluctuations can be obtained from the individual species number fluctuations 
and cross species number fluctuations given by Eq. 6. For a two-component system it is 
known that the matrix of the individual species and cross species number fluctuations is the 
inverse of the matrix formed with the derivative of the chemical potentials.28-30 It is easy to 
prove that this result is also applicable to multicomponent systems.  Therefore, we have, 
 
 
 
 
 
    
    
 
        
  
   
    
 
        
   
    
    
 
        
  
   
    
 
         
 
 
 
  
 
 
 
 
     
   
 
        
  
    
   
 
        
   
     
   
 
        
  
    
   
 
         
 
 
 
  
             
 
 
In order to calculate the matrix  
   
  
  an analytical theory is needed. Fortunately, such a 
theory is readily available in the literature. For a system of pure component hard spheres,  
Wertheim14 and Thiele15 succeeded in obtaining an exact solution of the P-Y integral 
equation for the radial distribution function g(r). For a system consisting of a mixture of 
hard spheres, Lebowitz16,17 has obtained an exact solution, which we use here in the 
calculation for the individual and cross species fluctuations. The expression for the chemical 
potential is obtained as,17 
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   is the diameter of a particle of the ith species,   is the mass of a particle of the ith species, 
        is the number density of the ith species, and h is Planck’s constant. 
 
                  
 
 
            
         
                                                   
 
Here   is the packing fraction i.e. the volume fraction occupied by granules in the tablet. 
From differentiation of Eq. 8, the matrix  
   
  
  can be easily constructed. Then the individual 
and cross species fluctuations can be calculated exactly through Eq. 7. This allows for the 
evaluation of CV from Eqs. 3-4. It is also possible to calculate CV directly from the individual 
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and cross species number fluctuations. An example to show this calculation is included in 
Results-Tableting study section. 
 
Tableting study 
 
To evaluate the predictions of the theoretical approach presented herein with experimental 
data an extensive tablet design study was conducted. To capture the impact of granule 
particle size on CU, two lots of granules - batch A and B - were manufactured, with batch A 
being smaller than batch B. The volume mean diameter of batch A granules was determined 
to be 317 micron, while for batch B granules it was 391 micron. Tablets with varying weight 
and loading of granules for each of the two granule batches were manufactured. The 
experimental plan of 9 tablet formulations for each granule batch is outlined in Table 1. A 
total of 54 independent tablet batches were manufactured to ensure that a reasonably large 
data set is available (three tablet batches were manufactured for each formulation). Thus, 
the tablet design study systematically explores the impact of three factors viz., the effect of 
percentage loading, tablet weight, and granule particle size on tablet CU. 
 
Diphenhydramine HCL was chosen as a model API. The API was granulated in a high shear 
granulator (KG-5L, Key International, Englishtown, NJ) and coated with Eudragit E100 
dissolved in ethyl alcohol in a bottom spray fluid bed processor (MP-1, Niro Aeromatic, 
Columbia, MD). The target potency for the coated granules was ~30% w/w. The granules 
were screened, and, for batch A particles larger than 30 mesh or smaller than 100 mesh 
were discarded. While for batch B, particles larger than 25 mesh or smaller than 120 mesh 
were discarded. The coated granules were blended with mannitol 60, granular mannitol 
2080, microcrystalline cellulose, and crospovidone in a V-blender (Patterson-Kelley, East 
Stroudsburg, PA) for 30 minutes. Following which magnesium stearate was added and the 
mixture was further blended for an additional 5 minutes. The granules were loaded at 5.0, 
12.5, and 25.0% w/w. The loading of the excipients were as follows: microcrystalline 
cellulose (10.0% w/w), crospovidone (6.0 % w/w), magnesium stearate (1.5 % w/w). 
Granular mannitol 2080 and mannitol 60 were loaded at 1:1 ratio to add up all ingredients 
to 100%. The blend was then compressed on a rotary tablet press (Piccola B10-C, Riva S.A. 
Argentina) using 4 stations at 40 and 25 rpm press and paddle speeds respectively. Batch 
size was  3800 tablets for each formulation studied. Tablet samples were collected in ten 
approximately equally spaced intervals throughout the batch. Three tablets per interval 
were analyzed for API content using UV/VIS spectrophotometry (Model 8453, Agilent 
Technologies, Santa Clara, CA) at wavelength of 258 nm. For each tablet formulation three 
independent batches were manufactured and analyzed for CU. The coated granules were 
also analyzed for particle size distribution using several screen sizes (25 – 120 US mesh) 
and assay for each sieve fraction was determined using spectrophotometry. The granule 
particle size and assay data are shown in Table 2.  
 
RESULTS 
 
Theoretical model 
 
Exact solution: 
 
The most direct evaluation of the CV without any approximations can be obtained by 
writing the variance in the drug content as follows: 
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The above method of calculating the CV is exact; however, it does not give us any insight 
into the different granule and tablet properties that collectively impact the CV. To 
understand that relationship between the variables involved we have to obtain an 
approximate expression for Var(N) in Eq. 3.  
 
Approximate solutions: 
 
In this section we show how an approximate expression for Var(N) can be derived. 
 
i) Single component system 
 
It is well known that for a pure component, the number fluctuations in a control volume V 
are given exactly as follows:31 
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 is the isothermal compressibility. For the evaluation of the isothermal 
compressibility, we use the equation of state (EOS) for pure component hard sphere 
systems obtained from the integral equation theory by Wertheim14 and Thiele15, 
 
   
 
 
      
      
                                                                                                                                           
 
This EOS results in the following expression for the isothermal compressibility, when terms 
up to   are retained: 
 
  
  
  
 
            
                                                                                                                              
 
Plugging Eq. 14 in Eq. 12 we find that the Var(N) for a pure component is given as: 
 
        
 
           
                                                                                                                         
 
Since both w and   are fixed for a pure component species, inserting Eq. 15 into Eqs. 2-4 we 
find that 
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Equation 16 is exact as it is derived from an analytical theory for single component hard 
spheres that has been shown to reliably describe fluid behavior up to at least a packing 
fraction of      .17 
 
ii) Multicomponent system 
 
For a multicomponent system, the term 
  
  
 no longer represents the total number 
fluctuations. For example, for a two component system (species 1,2), it can be shown with 
straightforward thermodynamics that:28-30 
 
       
  
  
      
  
 
             
 
              
                                                                                                  
 
where,     denotes the partial molar volume of species i. The cross-derivative       
        is non-positive, which makes the second term in Eq. 17 positive.
32 Thus, in this 
case, the term 
  
  
 captures only a portion of the total number fluctuations. 
 
For mixtures with >2 components, the expansion of total number fluctuations into 
contributions from compressibility and other contributions is non-trivial and is not 
discussed here. However, the two component mixture serves as a good example to highlight 
the fact that the total number fluctuations cannot be entirely derived from the isothermal 
compressibility for multicomponent systems. Therefore, unlike Eq. 16, which is exact for a 
single component system, only an approximate analytical expression for the CV can be 
obtained for multicomponent mixtures. However, in the following we find that in 
multicomponent systems for small      , the term 
  
  
 serves as a good approximation for 
the total number fluctuations. This approach to estimating the total number fluctuations 
allows us to understand the various factors that contribute to the CV in tablets and blends. 
 
From the EOS in Eq. 9 the isothermal compressibility for a multicomponent system of hard 
spheres can be obtained (only terms up to    are retained).17,18 Therefore, 
 
       
  
 
  
  
  
 
                              
                                                      
 
Where,  
                    
    
 
     
 
       
 
     
  
  
 
 
 
   
      
   
  
 
 
           
              
             
    
 
   
 
 
     
  
 
and    is the mole fraction of the ith species. 
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Note that Eq. 18 is exact as it is derived from an analytical theory for hard sphere mixtures 
that has been shown to reliably describe fluid behavior up to at least a packing fraction of 
      .18 
 
Inserting Eq. 18 into Eq. 3, we find that  
 
                       
                   
      
  
                             
                  
 
This shows that the CV is given as 
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The different grouped terms in the above equation are discussed in further detail in 
Discussion-Theoretical model section. 
 
Tableting study 
 
To show the predictions from the model and its comparison with the experimental data, at 
first the true density of the coated granules had to be obtained. This was performed by 
taking ~25 gm of the granules in a volumetric cylinder. To this, a non-interacting solvent 
(squalene) was added and mixed to displace all the air bubbles. The final volume of the 
mixture was noted. Taking into account the final volume of the mixture, density of squalene, 
and weight of granules, the true density of the granules for batch A and B was calculated to 
be 1.2 gm/cc. We assume that the true density for the different sieve cuts are very close and 
therefore use a single value for all based on the composite. 
 
Next, the packing fraction,  , in each tablet formulation had to be estimated. This was done 
by taking into account the blend density (  0.6 gm/cc, irrespective of granule loading), 
tablet weight, w/w percent loading of granules, and true density of granules. The calculated 
values are shown in Table 1. 
 
In Table 3 we show the calculations performed in estimating the various terms in Eq. 20. 
For each sieve cut, we use the median diameter of the particles for the calculation. In Table 
3, the number fraction of granules of each sieve cut were obtained by dividing the weight 
fraction with the cube of the median diameter and normalizing the ratios to add up to 1.0. 
This method is based on the assumption that the true density of each sieve fraction is 
identical. The weight of each bead was obtained by multiplying the volume of each bead 
with the true density. We obtain the following properties for the granules, batch A: 
       = 2.85E-11 gm2 and      = 2.95E-06 gm and batch B:        = 7.40E-11 
gm2 and      = 4.61E-06 gm. The number of granules of each sieve cut in a tablet, and 
the associated number densities,   , in a tablet for use in Eqs. 8 and 9 can be calculated from 
the volume of the granules of each sieve cut in a tablet and the volume of each granule of the 
sieve cut. From Eq. 18,    and    were calculated to be 0.1961 and 0.0773 respectively for 
batch A, and 0.2495 and 0.0991 respectively for batch B. 
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With the information in Tables 1, 2 and 3, the predicted CV from Eqs. 11 and 20 can be 
easily calculated. The predicted CVs from these equations, along with the experimentally 
measured tablet weight corrected CV (n=3 batches for each formulation) are shown in Table 
4. 
 
In these calculations, to obtain the individual number fluctuations, the matrix  
   
  
  was 
calculated by numerical differentiation of Eq. 8. The inverse matrix, viz.,  
  
   
  was obtained 
using the MINVERSE function in MS Excel. Then, the exact CV can be easily obtained through 
Eq. 11.  
 
Note: Each sieve fraction shown in Table 2 is considered as a species for the calculation 
with the theoretical model. This can be done because each sieve cut is approximated by the 
median diameter for its particles and they have a given assay fraction (f). Thus, we consider 
that are eight species of granules (m=8) within each granule batch A or B. However, the 
splitting of any granule batch into number of species is arbitrary (depending upon the 
sieves used) and the model can handle any level of approximation (      . The sieves 
shown in Table 2 were chosen because they allow for maximum resolution in the particle 
size range. The explicit calculations are shown in Table 3. 
 
Comparison to literature 
 
The theoretical model requires a large set of information for making predictions, such as for 
the granules (true density, particle size distribution, assay distribution), blend (bulk 
density, percentage granule load), and tablet weight. Unfortunately, at present, there is no 
study in the literature that reports all this data along with the experimental tablet CV. The 
only study that comes close to providing all required information is by Egermann et al.8,9 In 
this study, Egermann and coworkers used sucrose as a model drug in a mixture of 
sucrose/microcrystalline cellulose/talc and obtained the CV of sucrose in 50 mg and 200 mg 
tablets. The following ratios (w/w) of sucrose and microcrystalline cellulose/talc in the 
blend were studied:  10:90, 30:70, 50:50, and 80:20. The authors only reported the volume 
mean particle size of the ingredients (d50) as 504 micron and 60 micron for sucrose and 
microcrystalline cellulose/talc, respectively. Using this data and the reported values for 
other quantities, predictions for the CV from the theoretical model are shown in Table 5, 
along with predictions from Egermann’s model and experimental CV. Note that since only 
the d50 is available for the sucrose, it was approximated as a single species in the theoretical 
model and CV predictions were made using Eq. 16. Results from Table 5 show that the 
predictions of the present model reasonably agree with the predictions of the Egermann 
model. 
 
DISCUSSION 
 
Theoretical model 
 
Equation 20 allows us to clearly understand the contributions from various factors to the 
final content uniformity. The first ratio shows that the CV varies inversely with the square 
root of the dose if all other factors are fixed (granule particle size and assay distribution, 
granule loading). The second ratio shows how the granule characteristics with respect to 
particle size distribution and assay distribution with particle size impact the CV. The third 
term shows how the percent loading of granules (on a vol/vol basis) affects the CV, 
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although, this effect is coupled with the assay distribution of the granules through the term 
<w.f> and the particle size distribution through the terms y1 and y2. It can be seen that the 
CV is a complex function of the granule particle size and assay distribution, tablet volume, 
and granule loading. Therefore, it is not possible to generate a simplified nomograph e.g. for 
the limiting granule particle size distribution for passing the USP CU criteria as is available 
in the ideal mixing approximation from references 5-7. In this case, the limiting granule 
characteristics have to be obtained for each tablet formulation individually from the theory. 
 
Further insight from Eq. 20 can be obtained as follows. If the dose is fixed, but the tablet size 
is increased such that     (this will be the situation in low granule loading or low dose 
tablets), Eq. 20 evolves as: 
 
      
   
  
 
       
     
 
   
                                                                                                                     
 
Equation 21 shows that for a given dose the CV is determined by the ratio            
    . Thus, clearly, λ characterizes the “granule quality”. If λ is larger the CV is larger and 
vice versa. To ensure a low CV we must have as small λ as possible. From Table 3 we find 
that λ=9.66E-06 and 1.60 E-05 gm for granule batch A and B, respectively. 
 
If the particle size and its associated assay fraction are truly independent, one can write λ 
as: 
 
   
                          
       
                                                                                         
 
Where                  and                  denote the variance in 
the particle size distribution and assay with particle size distribution. Equation 22 shows 
that both the particle size distribution and assay with particle size distribution equally 
influence the granule quality and hence the CV of tablets. Thus it is not merely sufficient to 
have a narrow particle size distribution; attention should also be paid to the assay 
distribution. Note: If the particle size and its associated assay fraction are not independent, 
or, their degree of independence is not known, Eq. 22 should not be used for calculation of λ. 
The exact definition of λ should be used instead. 
 
A special case of Eq. 21 is when f is fixed (for granules) or f=1 (as in pure API particles). 
Then, the equation reduces to: 
 
              
   
  
 
      
   
 
   
                                                                                                         
 
Equation 23 is identical to one recently derived by Huang and Ku.7 This equation was shown 
to reliably predict the CV in low dose formulations with pure API particles. 
 
Another observation from the present study is that it is not always true that removing only 
larger particles will reduce the CV. For example, consider two cases for illustration i) if the 
particle assay is increasing with size and ii) when particle assay is decreasing with size. 
Representative plots for the product w.f of each particle with the number fraction in these 
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two granule systems are shown in Figure 2. Both granule systems have a fixed log-normal 
particle size distribution. The particle size is increasing on the x-axis from left to right for 
granules i while is it is decreasing in the same direction for granules ii. For both granules, it 
is found that λ can be decreased by removing particles of large values for w.f, which for 
granules ii is actually the smaller size particles. In our opinion, for any granule system 
removing particles of larger values for w.f should reduce λ. However, this needs to be 
evaluated further and could be verified on a case by case basis. 
 
Tableting study 
 
In Table 4, we find that the CV calculated through Eq. 20 is close to the CV obtained from the 
exact expression through Eq. 11. This closeness provides further proof that Eq. 20 is able to 
capture majority of the number fluctuations in typical blend or tablet formulations with 
relatively low packing fraction (     ).  It can be shown that with increasing   the fraction 
of the number fluctuations captured by the term 
  
  
 decreases. For example, in granule 
batch A it is found that the percentage of the total number fluctuations captured by the term 
  
  
 at                            are 92, 82, 67, and 50% respectively. Similar results are 
obtained for granule batch B tablet formulations. Therefore, at larger  , Eq. 20 becomes a 
less accurate approximation of Eq. 11. This is also apparent in Table 4 where the difference 
in the CV calculated through Eq. 11 and Eq. 20 increases with increasing granule loading i.e. 
 , for a fixed tablet weight. 
 
It should also be noted that during regular manufacturing a distribution in the measured CV 
exists due to the finite number of tablets that are analyzed in each batch, and also because 
there is batch to batch variability. The theoretical calculation of the CV through Eq. 11 gives 
the exact mean CV expected for an infinite number of tablets or batches assuming random 
mixing. The measured mean CV from production batches will always be higher than the 
predicted mean CV by the model. In addition, the model is not applicable in situations where 
the particle size of the API or granules is changing due to either agglomeration or de-
agglomeration during processing operations.33,34 
 
During manufacturing the CV may increase due to segregation in blending operations, 
dispensing, tableting operation, and other sources. Therefore, we have, 
 
     
        
             
                    
         
  
Or 
 
     
        
              
  
 
In the last column of Table 4 we calculate             
  as the difference between the exact CV 
(through Eq. 11) and the experimental mean CV. We find that             
  is roughly same for 
all the tablet formulations of a given weight. This is interesting as it suggests that the 
granule loading does not have a large impact on the degree of segregation. Two exceptions 
to this observation are the results for the 100 mg and 250 mg tablets made with granule 
batch B at 5% loading. In those cases,             
    0.8 and 0.9 respectively from Table 4. 
However, these results can be understood if we keep in mind that the experimental data 
was obtained for three independent batches and it is possible that the mean CV may change 
slightly if more batches are manufactured. For example, for the 5% loading in the 100 mg 
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tablet since the observed mean % CV is high (10.5), even a small rise in the mean CV (for e.g. 
to 11.1) can result in             
    13.8, which is in agreement with the rest of the data. 
Given that the CV values obtained for the three individual tablet batches of this formulation 
are 11.2, 11.0, and 9.4, this is a reasonable possibility. 
 
With both granule batches it is found that with increasing tablet weight             
  
significantly decreases. This suggests that the segregation arising from tableting operation 
can be reduced by making a larger tablet for a given dose. Although at fixed dose and 
increasing tablet size, the granule loading will decrease which will increase       . The 
increase in        may or may not offset the gain obtained from reduction in             
  and 
would need to be evaluated on a case by case basis. 
 
The larger values for             
  for the 100 mg tablet are not unexpected considering that 
filling a smaller tablet die is likely to be more difficult and involve more movement for the 
blend which can cause more segregation in the placement of granules in tablets. The results 
from Table 4 show that one can calculate             
   and that may allow us to predict the 
experimental CV (in combination with the theoretical model) for other products, or, at least 
other formulations with similar characteristics. 
 
It should be noted that the theoretical model has no fitting parameters, but is a direct 
calculation. The             
  represents all the contributions to the CU due to inefficient 
processing operations. 
 
Comparison to literature 
 
From Table 5 it is found that the predictions from the present model reasonably agree with 
the predictions from the model by Egermann.8,9 Although, for some formulations, 
predictions from both models are significantly lower than the experimental tablet CV (such 
as the 200 mg tablet with 10% w/w sucrose). This large difference in the CVs could be due 
to the large difference in particle size of the sucrose (504 micron) and microcrystalline 
cellulose/talc (60 micron) which is known to cause segregation problems during blend 
processing. In addition, the sucrose level is low, which is likely to worsen the effect of 
segregation. Thus, comparison to literature models and data shows that the current model 
is also consistent with them. However, the current model derives the factors affecting the CV 
from first principles and takes into account several features such as particle size 
distribution, assay distribution with particle size, among others, which is not available 
elsewhere. Note that in Table 5, the predicted CV from the theoretical model is always lower 
than the experimental CV because the blend will always have some degree of non-
randomness. 
 
CONCLUSIONS 
 
A generic and exact model for predicting content uniformity of granules in blend and tablet 
formulations is presented. The model exploits the fundamental theory behind particle 
number fluctuations in statistical mechanics to allow for the most accurate prediction of the 
mean CV under the assumption of random mixing. The predictions of the model serve as a 
theoretical lower limit for the mean CV (for infinite batches or tablets) that can be expected 
during manufacturing. The measured mean CV from production batches will be higher than 
the theoretical lower limit. A distinguishing feature of the present model is that it takes into 
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account the excluded volume of the granules in the formulation, and thus, allows us to study 
the effect of granule loading on the CV. Earlier models have mostly been based on the 
assumption of ideal mixing which ignores the excluded volume, and consequently, are 
incapable of incorporating the effect of granule loading. Our model also applies to 
formulations made with API particles as a special case. We also manufactured several tablet 
formulations with two lot of granules made from a model API to test the predictions from 
the theoretical model. It was found that the model is able to predict the experimental CV 
with good success and captures the effect of all elements (such as granule particle size, 
assay distribution with particle size, percentage loading, and tablet weight) that impact the 
CU as illustrated in the experimental data. An exact method for calculating the theoretical 
CV was presented along with analytical expressions which are an approximate solution. The 
approximate solutions give insight into the factors that contribute to the CV. It is shown that 
the CV varies inversely with the square root of the dose if all other factors are fixed (granule 
particle size and assay distribution, granule loading). We showed how the percent loading 
of granules (on a vol/vol basis) affects the CV, and, this effect is coupled with the 
characteristics of the granules. It was established that the CV is determined by the ratio 
                which characterizes the “granule quality”. If λ is larger, the CV is 
larger, and vice versa. To ensure a low CV we must have as small λ as possible. This ratio 
clearly shows the relation between granule properties and observed CV. It was argued that 
it is not always necessary to remove particles with larger size to reduce CV, but, instead 
remove particles with larger values for w.f which could be the smaller particles if the assay 
is decreasing with increasing particle size. Predictions from the current model also agreed 
reasonably with other models and literature data for CV. 
 
The theoretical method presented could be used to first obtain an estimate for             
  in 
the blend processing and tableting operations. Using the theoretical model and estimate for 
            
  it will be possible to then predict the experimental CV for products with similar 
characteristics (e.g. tablet weight, excipient size distribution). In summary, our theoretical 
model can help in guiding the formulations scientist for designing robust processes to meet 
the requirements for content uniformity. 
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GLOSSARY 
 
wi weight of each granule of type i 
fi fractional (w/w) assay of API in granule of type i 
m total number of granule types (i.e. sizes) 
µi chemical potential of granule of type i 
Ri diameter of granule of type i 
V volume corresponding to one tablet in the blend 
   number of granules of type i in the tablet 
   average number of granules of type i in the tablet 
N total number of granules in the tablet 
ai weight of the API in each granule of type i 
   weight of the API in granule j 
β 1/kT 
k Boltzmann’s constant 
T temperature in Kelvin 
P pressure 
   mass of a granule of type i 
   number density of granule of type i 
h Planck’s constant 
  packing fraction, i.e. volume fraction occupied by all granules in the tablet  
D dose 
      
   mean square number fluctuations in granule of type i 
             mean product of number fluctuations in granule of types i and j 
        total number fluctuations in volume V 
   isothermal compressibility 
    partial molar volume of granule type i 
   mole fraction of granule of type i 
   packing fraction of granule of type i 
CV percent coefficient of variation in the dose 
      percent coefficient of variation in the dose observed from experiments 
       percent coefficient of variation in the dose calculated from theory 
             
contribution to percent coefficient of variation in the dose from segregation 
during manufacturing operations 
λ parameter that characterizes “granule quality” 
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Figure 1. Scheme illustrating the approach of considering each blend volume equivalent to 
a tablet as an open system within the entire blend. The system is then modeled based on it’s 
analogy to thermodynamics of fluid mixtures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Entire blend 
Volume corresponding to 
1 tablet 

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Figure 2. An illustrative result for the possible distribution of the product w.f in granules, i) 
assay increasing with particle size, and, ii) assay decreasing with particle size. The particle 
size distribution is same for both granules. The particle size is increasing on the x-axis from 
left to right for granules i while is it is decreasing in the same direction for granules ii. For 
both granules, λ can be decreased by removing particles of large values for w.f 
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Table 1. Experimental plan for tablet manufacture 
 
 
Formulation 
number 
Particle 
loading 
(%w/w) 
Dose (mg) 
Batch A 
granules 
Dose (mg) 
Batch B 
granules 
Tablet weight (mg) 
and tooling size 
(inch) 
  
1 5.0 1.49 1.42 
100 (1/4) 
0.026 
2 12.5 3.72 3.54 0.065 
3 25.0 7.44 7.08 0.13 
4 5.0 3.72 3.54 
250 (5/16) 
0.026 
5 12.5 9.30 8.84 0.065 
6 25.0 18.60 17.69 0.13 
7 5.0 7.44 7.08 
500 (1/2) 
0.026 
8 12.5 18.60 17.69 0.065 
9 25.0 37.20 35.38 0.13 
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Table 2. Particle size distribution and assay for each sieve fraction for the coated granules 
 
Batch A 
 
Mesh size 
Diameter 
of granules 
(cm) 
Percent 
retained 
(w/w) 
Assay 
fraction of 
each cut 
30 0.0595 0.0 NA 
35 0.05 11.4 0.3317 
40 0.04 9.7 0.3285 
45 0.0354 13.1 0.3132 
50 0.0297 14.9 0.3081 
60 0.025 14.9 0.3014 
70 0.021 14.9 0.2959 
80 0.0177 12.4 0.2929 
100 0.0149 8.7 0.2871 
-30/+100 
composite 
NA 100 0.2976 
 
 
Batch B 
 
Mesh size 
Diameter 
of granules 
(cm) 
Percent 
retained 
(w/w) 
Assay 
fraction of 
each cut 
25 0.0707 0.0 NA 
30 0.0595 9.4 0.3023 
35 0.05 15.4 0.3024 
40 0.04 16.1 0.3011 
45 0.0354 18.5 0.2969 
50 0.0297 15.6 0.2939 
60 0.025 1.9 0.2882 
80 0.0177 20.8 0.2848 
120 0.0125 2.3 0.2610 
-25/+120 
composite 
NA 100 0.2826 
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Table 3. Calculation of granule characteristics 
 
Batch A 
 
Sieve cut 
US mesh 
Median 
Diameter 
(cm) 
% w/w 
retained 
Number 
fraction, 
p 
Assay 
fraction, 
f 
Volume of 
each bead, 
v (cm3) 
Weight of 
each bead, 
w (gm) 
API in 
each bead, 
a (gm) 
=p.w.f 
(gm) 
=p.      
(gm2) 
-30/+35 0.05475 11.4 0.01066 0.3317 8.59E-05 1.03E-04 3.42E-05 3.64E-07 1.24E-11 
-35/+40 0.045 9.7 0.01628 0.3285 4.77E-05 5.72E-05 1.88E-05 3.06E-07 5.75E-12 
-40/+45 0.0377 13.1 0.03733 0.3132 2.80E-05 3.36E-05 1.05E-05 3.93E-07 4.13E-12 
-45/+50 0.03255 14.9 0.06622 0.3081 1.80E-05 2.16E-05 6.65E-06 4.41E-07 2.93E-12 
-50/+60 0.02735 14.9 0.11162 0.3014 1.07E-05 1.28E-05 3.86E-06 4.31E-07 1.66E-12 
-60/+70 0.023 14.9 0.18769 0.2959 6.37E-06 7.64E-06 2.26E-06 4.24E-07 9.59E-13 
-70/+80 0.01935 12.4 0.26228 0.2929 3.79E-06 4.55E-06 1.33E-06 3.50E-07 4.66E-13 
-80/+100 0.0163 8.7 0.30792 0.2871 2.27E-06 2.72E-06 7.81E-07 2.40E-07 1.88E-13 
 Sum= 2.95E-06 2.85E-11 
 
 
Batch B 
 
Sieve cut 
US mesh 
Median 
Diameter 
(cm) 
% w/w 
retained 
Number 
fraction, 
p 
Assay 
fraction, 
f 
Volume of 
each bead, 
v (cm3) 
Weight of 
each bead, 
w (gm) 
API in 
each bead, 
a (gm) 
=p.w.f 
(gm) 
=p.      
(gm2) 
-25/+30 0.0651 9.4 0.00847 0.3023 1.44E-04 1.73E-04 5.22E-05 4.42E-07 2.31E-11 
-30/+35 0.05475 15.4 0.02337 0.3024 8.59E-05 1.03E-04 3.12E-05 7.28E-07 2.27E-11 
-35/+40 0.045 16.1 0.04404 0.3011 4.77E-05 5.72E-05 1.72E-05 7.59E-07 1.31E-11 
-40/+45 0.0377 18.5 0.08579 0.2969 2.80E-05 3.36E-05 9.98E-06 8.56E-07 8.54E-12 
-45/+50 0.03255 15.6 0.11268 0.2939 1.80E-05 2.16E-05 6.35E-06 7.15E-07 4.54E-12 
-50/+60 0.02735 1.9 0.02359 0.2882 1.07E-05 1.28E-05 3.70E-06 8.73E-08 3.23E-13 
-60/+80 0.02135 20.8 0.53240 0.2848 5.09E-06 6.11E-06 1.74E-06 9.26E-07 1.61E-12 
-80/+120 0.0151 2.3 0.16967 0.2610 1.80E-06 2.16E-06 5.64E-07 9.57E-08 5.39E-14 
 Sum= 4.61E-06 7.40E-11 
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Table 4. Predicted % CVs obtained from the theoretical model along with the observed 
tablet weight corrected % CV (shown is the mean and for individual batches, n=3) 
 
 
Batch A granules 
 
Particle 
loading 
(%w/w) 
Tablet 
weight 
(mg) 
CV 
Eq. 11 
CV 
Eq. 20 
CV 
Observed 
(tablet weight corrected) 
            
  
5.0 
100  
7.66 7.87 8.3 (8.9, 7.0, 9.0) 10.2 
12.5 4.39 4.83 6.1 (6.8, 6.4, 5.2) 17.9 
25.0 2.53 3.30 4.7 (4.0, 5.5, 4.7) 15.7 
5.0 
250  
4.85 4.98 4.7 (4.2, 5.7, 4.3) NA 
12.5 2.77 3.06 3.7 (3.7, 3.5, 4.0) 6.0 
25.0 1.60 2.09 2.2 (2.2, 1.8, 2.5) 2.3 
5.0 
500 
3.43 3.52 3.6 (3.1, 4.0, 3.8) 1.2 
12.5 1.96 2.16 2.6 (2.5, 2.9, 2.4) 2.9 
25.0 1.13 1.48 1.9 (1.8, 2.0, 2.0) 2.3 
 
 
 
Batch B granules 
 
Particle 
loading 
(%w/w) 
Tablet 
weight 
(mg) 
CV 
Eq. 11 
CV 
Eq. 20 
CV 
Observed 
(tablet weight corrected) 
            
  
5.0 
100 
10.46 10.42 10.5 (11.2, 11.0, 9.4) 0.8 
12.5 6.04 6.42 7.2 (8.3, 7.9, 5.5) 15.4 
25.0 3.42 4.40 5.0 (4.6, 5.3, 5.2) 13.3 
5.0 
250 
6.63 6.59 6.7 (6.8, 6.7, 6.7) 0.9 
12.5 3.82 4.06 4.7 (4.8, 4.8, 4.5) 7.5 
25.0 2.16 2.78 2.9 (2.6, 3.0, 3.2) 3.7 
5.0 
500 
4.69 4.66 4.3 (4.0, 4.9, 4.1) NA 
12.5 2.70 2.87 3.0 (3.1, 2.7, 3.3) 1.7 
25.0 1.53 1.97 2.2 (1.9, 2.4, 2.4) 2.5 
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Table 5. Predicted mean % CV for sucrose in tablets made from sucrose/microcystalline 
cellulose/talc mixtures along with the observed experimental % CV (n=2) 
 
 
 
50 mg tablets 
 
Sucrose 
(%w/w) 
Mean %CV 
predicted by Eq. 16 
Mean %CV from 
Egermann’s theory8,9 
Experimentally 
measured %CV 
10 13.1 14.4 NA 
30 6.2 8.2 NA 
50 3.6 4.0 3.9,4.1 
80 1.7 2.2 1.8,2.2 
 
 
 
200 mg tablets 
 
Sucrose 
(%w/w) 
Mean %CV 
predicted by Eq. 16 
Mean %CV from 
Egermann’s theory8,9 
Experimentally 
measured %CV 
10 6.6 7.1 9.7,10.1 
30 3.1 4.0 4.7,4.6 
50 1.8 2.0 2.2,2.1 
80 0.9 1.1 2.0,2.6 
 
 
 
